TEM insider notice: J.P. Morgan to handle 332,500-share sale on Nasdaq
Rhea-AI Filing Summary
Tempus AI, Inc. (TEM) filed a Form 144 notifying a proposed sale of 332,500 Class A common shares through J.P. Morgan Securities LLC with an aggregate market value of $27,973,225, to be sold on 09/25/2025 on Nasdaq. The filing lists the issuer and multiple acquisition lots for the shares, including stock compensation and direct investments dated between 2016 and 2024. The form also discloses several sales by related parties in the prior three months, including individual transactions on 07/28/2025, 08/19/2025, and 08/27/2025. The signer certifies no undisclosed material adverse information and references Rule 10b5-1 procedures if applicable.
Positive
- Clear compliance disclosure of proposed sale details including broker, share count, market value, and planned sale date
- Acquisition history provided showing provenance of the shares (stock compensation and direct investments)
- Recent sales disclosed for the prior three months, improving transparency about insider liquidity
Negative
- Insider/affiliated selling activity is evident with multiple sizeable dispositions reported in the past three months
- No information provided in the filing about whether a Rule 10b5-1 trading plan is in place (date not indicated)
Insights
TL;DR: Insider-related holders plan to sell 332,500 Class A shares via J.P. Morgan; several sizable insider sales occurred in prior three months.
The Form 144 outlines a proposed market sale of 332,500 Class A shares with an indicated aggregate market value of $27,973,225, scheduled through J.P. Morgan on Nasdaq. The filing documents acquisition dates and types, including stock compensation on 06/14/2024 and multiple direct investments back to 2016. The record of sales during the past three months shows multiple dispositions by named accounts, demonstrating recent liquidity events by insiders or affiliated entities. The filing includes the standard representation regarding absence of undisclosed material adverse information and notes potential reliance on Rule 10b5-1 if a trading plan exists.
TL;DR: Routine insider disclosure; provides transparency on provenance of shares and recent insider sales but no new operational information.
The Form 144 provides the necessary disclosure for a proposed sale under Rule 144: broker identity, class of shares, acquisition history, and recent dispositions. Acquisition entries specify stock compensation and multiple direct investments, which clarifies that the shares originate from both compensation and purchases. The document is procedural and focuses on compliance and transparency rather than operational or financial developments for the issuer.
FAQ
What does Tempus AI's Form 144 disclose about the proposed sale of TEM shares?
Who is the broker handling the proposed sale in the Form 144 for TEM?
What is the origin of the shares to be sold according to the Form 144?
Were there recent sales of TEM shares by related parties before this Form 144?
Does the Form 144 state whether the seller has undisclosed material information or a 10b5-1 plan?